Tianjin Tianyao Pharmaceuticals Co., Ltd.

Tianjin Tianyao Pharmaceuticals Co., Ltd. faced notable stock activity, declining significantly amid ongoing financial struggles. The company reported consecutive quarterly losses, a low Return on Capital Employed, and a decrease in net sales and operating profit over five years, alongside a high valuation and modest dividend yield.

Tianjin Tianyao Pharmaceuticals Co., Ltd. saw a notable increase in its stock performance, gaining 8.78% on July 13, 2026, while the broader market declined. The company has shown strong growth over the past month and year, despite facing challenges in management efficiency and negative sales growth.

Tianjin Tianyao Pharmaceuticals Co., Ltd. has seen significant stock gains today, contrasting with a decline in the broader market. Despite recent performance improvements, the company struggles with low profitability metrics and negative growth in net sales and operating profit over the past five years, raising concerns about its financial stability.

Tianjin Tianyao Pharmaceuticals Co., Ltd. saw a notable increase in its stock today, contrasting with the broader market's modest rise. However, the company faces ongoing financial challenges, including a decline in profits and low return on capital employed, alongside stagnant sales growth and reduced operating profits over the past five years.

Tianjin Tianyao Pharmaceuticals Co., Ltd. saw a notable increase in its stock today, contrasting with a decline in the broader market. Year-to-date, the company has outperformed the China Shanghai Composite, but faces challenges with low profitability metrics and negative growth in net sales and operating profit over the past five years.

Tianjin Tianyao Pharmaceuticals Co., Ltd. faced a notable decline in its stock today, contrasting with the broader market. Despite a positive annual performance, the company has struggled recently, showing significant decreases over the past week and month, alongside low returns and negative growth metrics, raising concerns about its future.

Tianjin Tianyao Pharmaceuticals Co., Ltd. saw a notable increase in its stock today, contrasting with a decline in the broader market. While the company has shown resilience in annual performance, challenges remain, including low management efficiency and declining long-term growth metrics. Investors will be watching these trends closely.

Tianjin Tianyao Pharmaceuticals Co., Ltd. has seen a notable increase in stock performance, achieving an intraday high of CNY 4.33. Despite recent gains, the company faces challenges such as low Return on Capital Employed and declining net sales and operating profit over the past five years.

Tianjin Tianyao Pharmaceuticals Co., Ltd. faced a notable stock decline, significantly underperforming the broader market. The company reported a substantial drop in net profit and has experienced consecutive quarters of negative results. Long-term growth metrics reveal challenges, including declining sales and low return on capital employed.